CEO tackles upoar over drug prices witn PR campaign, proactive agenda Stephen Ubl knows this old adage well: If you're not telling your story, somebody else is. Outrage about jacked-up prices for old medicines dominated the headlines in September 2015, just days before the Pharmaceutical Research and Manufacturers of America announced Ubl as the group's new CEO. "Pharma Bro" Martin Shkreli became a symbol of perceived industry greed. Since then, Ubl has led industry efforts to tell a different story—one focused on researchers finding life-saving treatments. "The narrative around the work of those researchers had really been hijacked by Martin Shkreli and several other… Read More